Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors
1 other identifier
interventional
64
1 country
1
Brief Summary
This study aims to examine the effects of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedStudy Start
First participant enrolled
April 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2025
CompletedAugust 5, 2025
February 1, 2025
3 months
February 23, 2025
July 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heartland Forgiveness Scale
The scale, which evaluates the level of forgiveness and consists of 18 items, consists of three sub-dimensions: "forgiveness of self", "forgiveness of others" and "forgiveness of the situation". The items of the Likert-type scale are evaluated according to a 7-point evaluation scale and the evaluation is answered as "does not reflect me at all" (1 point), "does not reflect me very much" (3 points), "reflects me a little" (5 points) and "reflects me completely" (7 points). Items 2, 4, 6, 7, 9, 11, 13, 15 and 17 in the scale items are scored reversely. The scale is evaluated according to total and sub-scale scores and there is no cut-off score. High scores obtained from each of the sub-dimensions of the scale indicate a high or low level of forgiveness in the relevant sub-dimension. The total forgiveness score is formed by summing the scores of the sub-dimensions of the scale.
Baseline, 6 th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
Secondary Outcomes (2)
Brief Symptom Inventory
Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
Fear of Cancer Recurrence Inventory
Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
Other Outcomes (1)
Introductory Information Form
Baseline, 1st month follow-up, 3rd month follow-up (Pre-test-post-test follow-up experimental design)
Study Arms (2)
Forgiveness-Based Group Psychoeducation
EXPERIMENTALForgiveness-based group psychoeducation to be conducted with the experimental group is planned as 6 sessions. The sessions are planned to be conducted in 3 groups of 8-10 people. The duration of a session is planned to be approximately 90 minutes. Group psychoeducation with the experimental group will be conducted face-to-face every week. The appropriate day for the sessions will be decided with the members of each group. The same group sessions will be conducted on the same day and time every week.
No Intervention
NO INTERVENTIONAfter the follow-up tests were completed, it was planned to implement the 6-session forgiveness-based group psychoeducation applied to the intervention group in the same way upon the request of the control group.
Interventions
The effect of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric conditions.
Eligibility Criteria
You may qualify if:
- Written and verbal consent to participate in the study
- Understanding and speaking Turkish
- Being over 18 years old
- Not having any visual, hearing or mental disabilities
- Having been diagnosed with cancer, treated with curative intent and having completed major treatments (surgery, radiotherapy, chemotherapy) within the last 5 years
You may not qualify if:
- Not volunteering to participate in research
- Having a visual, hearing or mental disability
- Agreeing to participate in another psychoeducational program conducted simultaneously with the research
- Inability to communicate in Turkish
- Having previously received training in forgiveness and/or coping with fear of relapse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hilal Merve Belenlead
- Saglik Bilimleri Universitesicollaborator
Study Sites (1)
Gülhane Health Sciences Institute
Ankara, Keçiören, 06010, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Gamze Sarıkoç, Associate Professor
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The process of assigning participants to groups will be carried out by a statistician outside the study using the simple randomization method and will be hidden from the researcher until the application begins. Since the assignment to groups will be made after informed consent is obtained, the participants will be blinded (single blind). In addition, the statistician will also be blinded in order to reduce statistical analysis and reporting bias. Without specifying which group (intervention and control group) the data belong to, they will be coded and transferred to the database (group A, group B), and the data will be analyzed and reported.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 23, 2025
First Posted
March 10, 2025
Study Start
April 2, 2025
Primary Completion
July 1, 2025
Study Completion
July 14, 2025
Last Updated
August 5, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share